Objective: To identify incidence and determinant of new-onset of diabetes after transplant (NODAT) in Indian renal transplant recipients.Methods: In this study Indian renal transplant recipients who were not diabetic before transplant and underwent kidney transplantation between July 2004 and June 2011 were enrolled. Various data of all transplant patients including age, gender, body weight, pre transplant Hepatitis C virus (HCV), Hepatitis B virus (HBV) infection status, Human Leukocyte Antigens (HLA) mismatch, maintenance immunosuppressant drug, usage of antibodies, anti rejection treatment, patients and graft survival, post-transplant infection including HCV, HBV, Herpes and Cytomegalo virus (CMV) infection were noted down. In this study...
Background. The outcome of renal transplantation depends on achieving effective immunosuppression wh...
Aims. To determine: (i) the incidence of new-onset diabetes mellitus in patients after renal transpl...
Aim. To analyze the modes of immunosuppressive therapy as a risk factor for new-onset diabetes after...
Background: New onset diabetes after transplantation (NODAT) is a common entity in the post-transpla...
Objective: The objective of present study was to evaluate incidence and risk factors for the develop...
New-onset diabetes after transplant (NODAT) has been reported to occur in 4%-25% of renal transplant...
Introduction: New-onset diabetes mellitus after transplantation (NODAT) is a major complication of r...
New Onset Diabetes after Transplantation (NODAT) is a common complication of renal transplantation w...
Phuong-Thu T Pham1, Phuong-Mai T Pham2,3, Son V Pham4, Phuong-Anh T Pham5, Phuong-Chi T Pham2,61Neph...
New-Onset Diabetes After Transplantation (NODAT) is an increasingly recognized severe metabolic comp...
New-Onset Diabetes After Transplantation (NODAT) is an increasingly recognized severe metabolic comp...
New-Onset Diabetes After Transplantation (NODAT) is an increasingly recognized severe metabolic comp...
Objectives: This study aimed to determine the pre-transplant risk factors as independent predictors ...
New-onset diabetes after transplantation (NODAT) is an important metabolic complication of transplan...
Background: New-onset diabetes after transplantation (NODAT) is associated with reduced patient and ...
Background. The outcome of renal transplantation depends on achieving effective immunosuppression wh...
Aims. To determine: (i) the incidence of new-onset diabetes mellitus in patients after renal transpl...
Aim. To analyze the modes of immunosuppressive therapy as a risk factor for new-onset diabetes after...
Background: New onset diabetes after transplantation (NODAT) is a common entity in the post-transpla...
Objective: The objective of present study was to evaluate incidence and risk factors for the develop...
New-onset diabetes after transplant (NODAT) has been reported to occur in 4%-25% of renal transplant...
Introduction: New-onset diabetes mellitus after transplantation (NODAT) is a major complication of r...
New Onset Diabetes after Transplantation (NODAT) is a common complication of renal transplantation w...
Phuong-Thu T Pham1, Phuong-Mai T Pham2,3, Son V Pham4, Phuong-Anh T Pham5, Phuong-Chi T Pham2,61Neph...
New-Onset Diabetes After Transplantation (NODAT) is an increasingly recognized severe metabolic comp...
New-Onset Diabetes After Transplantation (NODAT) is an increasingly recognized severe metabolic comp...
New-Onset Diabetes After Transplantation (NODAT) is an increasingly recognized severe metabolic comp...
Objectives: This study aimed to determine the pre-transplant risk factors as independent predictors ...
New-onset diabetes after transplantation (NODAT) is an important metabolic complication of transplan...
Background: New-onset diabetes after transplantation (NODAT) is associated with reduced patient and ...
Background. The outcome of renal transplantation depends on achieving effective immunosuppression wh...
Aims. To determine: (i) the incidence of new-onset diabetes mellitus in patients after renal transpl...
Aim. To analyze the modes of immunosuppressive therapy as a risk factor for new-onset diabetes after...